local_hospital

Multiprofile Hospital For Active Treatment Eurohospital OOD

Address
Ulitsa Nayden Raykov 2a, 9022 Varna, Bulgaria

Multiprofile Hospital For Active Treatment Eurohospital OOD

Eurohospital is a comprehensive medical facility engaged in clinical research focused on musculoskeletal disorders and pain management. The center specializes in investigating innovative therapeutic approaches for patients suffering from debilitating joint conditions, with particular emphasis on osteoarthritis and associated chronic pain syndromes.

  • Intra-articular injection therapies for osteoarthritis management
  • Safety and tolerability assessments of novel pain relief interventions
  • Treatment of moderate to severe knee osteoarthritis

The hospital's research infrastructure supports open-label clinical trials examining cutting-edge pharmaceutical interventions. Their work with RTX-GRT7039 demonstrates commitment to advancing treatment options for patients experiencing significant pain from degenerative joint disease, contributing valuable data on the safety profile of emerging intra-articular therapeutics in the field of rheumatology and orthopedic medicine.

Site Overview

assignment
1
connected trial
corporate_fare
1
sponsor
science
2
IMPs

Activity Indicator

Last 6 months

0
Trials started
0
Trials started 6–12 months ago
1
Total trials linked
Low Activity
trending_flatStable0%
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
0
Sponsors (total)
1
Active sponsors
0

Sponsor Network

Top 10 by active trials.

No sponsors linked to active trials.

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

No repeated partnerships found.

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 476 other sites in Bulgaria

description
Trial volume
1
Outperforms 0% of sites
public
Therapeutic diversity
1areas
Outperforms 0% of sites
groups
Sponsor diversity
1sponsors
Outperforms 0% of sites

Therapeutic Area Benchmark — Bulgaria

Select a therapeutic area to compare against other sites in Bulgaria.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Bulgaria

Market Share

Country: Bulgaria

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Multiprofile Hospital For Active Treatment Eurohospital OOD

Trial Sponsor Phase Status Start Date End Date
Evaluation of Safety and Tolerability of Intra-Articular Resiniferatoxin and Ropivacaine Hydrochloride in Moderate to Severe Knee Osteoarthritis PainGruenenthal GmbHPhase IIINot RecruitingJul 2022Mar 2025

IMP list

lock Showing 1 of 2 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Resiniferatoxin1Unknown2022-07-262022-07-26

Request feasibility information

Ask this centre about capacity, equipment and patient population.

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.